-
Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research programChild, Christopher J. ...BACKGROUND: GH has an insulin antagonist effect, and GH treatment has therefore been suggested to impair glucose metabolism and increase risk of diabetes mellitus. SETTING: Data from 11,686 ... GH-treated patients in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS), a multinational observational study of children with growth disorders, were analyzed for diabetes incidence. Baseline diabetes prevalence was determined from a GH-naive subgroup. METHODS: Prevalence and incidence (bystandardized incidence ratio) were compared with results from patients agedless than 20 yr in the U.S. SEARCH for Diabetes in Youth study. RESULTS: Baseline type 1 diabetes prevalence per 1000 persons was 4.92 (95% confidenceinterval = 1.91-12.58) in GeNeSIS and 1.03 (0.97-1.10) in SEARCH for0- to 9-yr-olds, and 7.33 (4.20-12.77) and 2.99 (2.78-2.98), respectively, for 10- to 19-yr-olds; there were no GeNeSIS cases of type 2 diabetes before GH initiation. During a median 1.8 yr of GH treatment, diabetes standardized incidence ratios for U.S. patients were 1.4 (0.5-3.1) for type 1 and 8.5 (2.8-19.5) for type 2, and for all patients was 1.4 (0.7-2.4) for type 1 and 6.5 (3.3-11.7) for type 2. Among the 11 patients with incident type 2 diabetes, risk factors for diabetes were identified in 10 patients. Glucose concentrations normalized for seven of nine patients for whom glycemic status could be determined (three of whom continued GH therapy and four who discontinued). CONCLUSION: The incidence of type 2 diabetes was higher in GH-treated children than the general population. Monitoring of glucose, beforeand periodically during GH treatment, is recommended for those with preexisting type 2 diabetes risk factors.Vir: The Journal of clinical endocrinology & metabolism. - ISSN 0021-972X (Vol. 96, no. 6, 2011, str. E1025-E1034)Vrsta gradiva - članek, sestavni delLeto - 2011Jezik - angleškiCOBISS.SI-ID - 29622745
Avtor
Child, Christopher J. |
Zimmermann, Alan G. |
Scott, Robin S. |
Cutler, Gordon B. |
Battelino, Tadej |
Blum, Werner F.
Teme
Diabetes Mellitus |
Epidemiology |
Diagnosis |
Prevalence |
Incidence |
Growth Disorders |
Drug Therapy |
Somatotropins, Recombinant |
Glucose Tolerance Test |
Adolescence |
Child |
Body Mass Index |
Risk Factors |
Incidenca |
Rast, motnje |
Sladkorna bolezen |
Somatotropini rekombinanti |
Prevalenca |
Adolescenca |
Otrok |
Glukoza, tolerančni test |
Telesna masa, indeks |
Dejavniki tveganja
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Child, Christopher J. | ![]() |
Zimmermann, Alan G. | ![]() |
Scott, Robin S. | ![]() |
Cutler, Gordon B. | ![]() |
Battelino, Tadej | 13023 |
Blum, Werner F. | ![]() |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.